Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag RAPT Therapeutics raised $250 million by selling 8.3 million shares at $30 each, with an option for underwriters to buy more.

flag RAPT Therapeutics priced a public offering of 8.3 million shares at $30 each, raising about $250 million before expenses, with underwriters holding an option to buy 1.25 million more shares. flag The offering, managed by several investment banks, is set to close around October 23, 2025, subject to standard conditions. flag Shares are being offered under a prior SEC shelf registration. flag The company warns that actual results may differ due to market and regulatory risks, as outlined in its SEC filings.

4 Articles